Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Nippon Chemiphar patents

Patents where

Current Assignee

Name

‌

Nippon Chemiphar

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9382236 P2X4 receptor antagonist	Patent 9382236 was granted and assigned to Nippon Chemiphar on July, 2016 by the United States Patent and Trademark Office.	‌ Nippon Chemiphar	‌ Nippon Chemiphar	United States Patent and Trademark Office	9382236	July 5, 2016
‌ US Patent 9969700 P2X4 receptor antagonist	Patent 9969700 was granted and assigned to Nippon Chemiphar on May, 2018 by the United States Patent and Trademark Office.	‌ Nippon Chemiphar	‌ Nippon Chemiphar	United States Patent and Trademark Office	9969700	May 15, 2018
‌ US Patent 11278528 Activator of peroxisome proliferator-activated receptor	Patent 11278528 was granted and assigned to Nippon Chemiphar on March, 2022 by the United States Patent and Trademark Office.	‌ Nippon Chemiphar	‌ Nippon Chemiphar	United States Patent and Trademark Office	11278528	March 22, 2022
‌ US Patent 11633392 Use of morphinan derivative for therapeutic treatment of opioid delta receptor agonist-related disease	Patent 11633392 was granted and assigned to Nippon Chemiphar on April, 2023 by the United States Patent and Trademark Office.	‌ Nippon Chemiphar	‌ Nippon Chemiphar	United States Patent and Trademark Office	11633392	April 25, 2023
‌ US Patent D953563 Analysis equipment for medical use	Patent D953563 was granted and assigned to Nippon Chemiphar on May, 2022 by the United States Patent and Trademark Office.	‌ Nippon Chemiphar	‌ Nippon Chemiphar	United States Patent and Trademark Office	D953563	May 31, 2022
‌ US Patent 10442802 Morphinan derivative	Patent 10442802 was granted and assigned to Nippon Chemiphar on October, 2019 by the United States Patent and Trademark Office.	‌ Nippon Chemiphar	‌ Nippon Chemiphar	United States Patent and Trademark Office	10442802	October 15, 2019
‌ US Patent 11643411 Morphinan derivative	Patent 11643411 was granted and assigned to Nippon Chemiphar on May, 2023 by the United States Patent and Trademark Office.	‌ Nippon Chemiphar	‌ Nippon Chemiphar	United States Patent and Trademark Office	11643411	May 9, 2023
‌ US Patent D953570 Reagent cartridge	Patent D953570 was granted and assigned to Nippon Chemiphar on May, 2022 by the United States Patent and Trademark Office.	‌ Nippon Chemiphar	‌ Nippon Chemiphar	United States Patent and Trademark Office	D953570	May 31, 2022
‌ US Patent 8673915 P 2×4 receptor antagonist	Patent 8673915 was granted and assigned to Nippon Chemiphar on March, 2014 by the United States Patent and Trademark Office.		‌ Nippon Chemiphar	United States Patent and Trademark Office	8673915	March 18, 2014
‌ US Patent 8404726 Activating agent for peroxisome proliferator activated receptor δ	Patent 8404726 was granted and assigned to Nippon Chemiphar on March, 2013 by the United States Patent and Trademark Office.		‌ Nippon Chemiphar	United States Patent and Trademark Office	8404726	March 26, 2013
‌ US Patent 7652045 Activator of peroxisome proliferator-activated receptor δ	Patent 7652045 was granted and assigned to Nippon Chemiphar on January, 2010 by the United States Patent and Trademark Office.		‌ Nippon Chemiphar	United States Patent and Trademark Office	7652045	January 26, 2010
‌ US Patent 7648999 Activator for peroxisome proliferator-activated receptor δ	Patent 7648999 was granted and assigned to Nippon Chemiphar on January, 2010 by the United States Patent and Trademark Office.		‌ Nippon Chemiphar	United States Patent and Trademark Office	7648999	January 19, 2010
‌ US Patent 10995092 Morphinan derivative	Patent 10995092 was granted and assigned to Nippon Chemiphar on May, 2021 by the United States Patent and Trademark Office.	‌ Nippon Chemiphar	‌ Nippon Chemiphar	United States Patent and Trademark Office	10995092	May 4, 2021
‌ US Patent 8648208 Activating agent for peroxisome proliferator activated receptor	Patent 8648208 was granted and assigned to Nippon Chemiphar on February, 2014 by the United States Patent and Trademark Office.		‌ Nippon Chemiphar	United States Patent and Trademark Office	8648208	February 11, 2014
‌ US Patent 10292974 Prophylactic or therapeutic agent for giant cell tumors occurring in bone and soft tissue or for chondrosarcoma	Patent 10292974 was granted and assigned to Nippon Chemiphar on May, 2019 by the United States Patent and Trademark Office.	‌ Nippon Chemiphar	‌ Nippon Chemiphar	United States Patent and Trademark Office	10292974	May 21, 2019
‌ US Patent 11434207 P2X4 receptor antagonist		‌ Nippon Chemiphar	‌ Nippon Chemiphar	United States Patent and Trademark Office	11434207	September 6, 2022
‌ US Patent 8680110 P2X	Patent 8680110 was granted and assigned to Nippon Chemiphar on March, 2014 by the United States Patent and Trademark Office.		‌ Nippon Chemiphar	United States Patent and Trademark Office	8680110	March 25, 2014
‌ US Patent 8778933 Diazepinedione derivative		‌ Nippon Chemiphar	‌ Nippon Chemiphar	United States Patent and Trademark Office	8778933	July 15, 2014
‌ US Patent 10660882 Prophylactic or therapeutic agent for giant cell tumors occurring in bone and soft tissue or for chondrosarcoma	Patent 10660882 was granted and assigned to Nippon Chemiphar on May, 2020 by the United States Patent and Trademark Office.	‌ Nippon Chemiphar	‌ Nippon Chemiphar	United States Patent and Trademark Office	10660882	May 26, 2020
‌ US Patent 7402597 Activator of peroxisome proliferator-activated receptor δ	Patent 7402597 was granted and assigned to Nippon Chemiphar on July, 2008 by the United States Patent and Trademark Office.		‌ Nippon Chemiphar	United States Patent and Trademark Office	7402597	July 22, 2008
‌ US Patent 10653667 Drug for preventing, treating or preventing metastasis of giant cell tumor that occurs in bone or soft parts, chondrosarcoma, or osteosarcoma, local injection for arterial embolization, and artificial bone	Patent 10653667 was granted and assigned to Nippon Chemiphar on May, 2020 by the United States Patent and Trademark Office.	‌ Nippon Chemiphar	‌ Nippon Chemiphar	United States Patent and Trademark Office	10653667	May 19, 2020
‌ US Patent 10633349 P2X4 receptor antagonist		‌ Nippon Chemiphar	‌ Nippon Chemiphar	United States Patent and Trademark Office	10633349	April 28, 2020
‌ US Patent 7078422 Activator for peroxisome proliferator-activated receptor	Patent 7078422 was granted and assigned to Nippon Chemiphar on July, 2006 by the United States Patent and Trademark Office.		‌ Nippon Chemiphar	United States Patent and Trademark Office	7078422	July 18, 2006
‌ US Patent 11666582 Medicament for treating cough			‌ Nippon Chemiphar	United States Patent and Trademark Office	11666582	June 6, 2023

24 results

0 selected

24 results

0 selected